Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) EBITDA Margin (2009 - 2026)

Updated

Bristol Myers Squibb's EBITDA Margin was 24.19% in Q3 2026, down 9.56 percentage points from 33.75% a year earlier and down 11.88 percentage points from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) EBITDA Margin (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Bristol Myers Squibb's EBITDA Margin was 28.23% through Sep 30, 2026, up 1.27 percentage points year-over-year; for FY2025, it came in at 27.68%, up 25.15 percentage points from FY2024.

  • EBITDA Margin shows a five-year change of +19.42 percentage points (FY2020 to FY2025).
  • In earlier years, EBITDA Margin was 2.53% in FY2024 (-37.91 pp), 40.44% in FY2023 (+1.47 pp), 38.97% in FY2022 (-1.52 pp) and 40.50% in FY2021 (+32.24 pp).
  • Quarterly EBITDA Margin has moved between -75.72% (Q1 2024) and 45.86% (Q1 2023) over five years.
  • Compared with a year earlier, EBITDA Margin was higher in three of the last eight quarters, with an average year-over-year change of +10.65 percentage points.
  • The best year-over-year quarter for EBITDA Margin over five years was Q1 2025 (a gain of 111.28 percentage points); the worst was Q1 2024 (a drop of 121.58 percentage points).
  • Per Business Quant data, BMY's EBITDA Margin in the three quarters before Q3 2026 was 36.07% (Q2 2026), 33.36% (Q1 2026) and 19.57% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 32.68%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 46.88%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 40.60%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 39.77%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 46.62%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 50.63%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 42.49%
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 24.19%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 24.19%
Jun 30, 2026 36.07%
Mar 31, 2026 33.36%
Dec 31, 2025 19.57%
Sep 30, 2025 33.75%
Jun 30, 2025 22.69%
Mar 31, 2025 35.56%
Dec 31, 2024 16.65%
Sep 30, 2024 35.89%
Jun 30, 2024 31.82%
Mar 31, 2024 -75.72%
Dec 31, 2023 36.05%
Sep 30, 2023 41.69%
Jun 30, 2023 38.22%
Mar 31, 2023 45.86%
Dec 31, 2022 38.40%
Sep 30, 2022 42.76%
Jun 30, 2022 38.20%
Mar 31, 2022 36.67%
Dec 31, 2021 37.02%
API Access

Bristol Myers Squibb EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BMY&period=max&api_key=YOUR_API_KEY